Abstract
We would like to share ideas on the publication “Fewer head and neck cancer (HNC) diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis [1].” Schoonbeek et al. noted that “the incidence of HNC during the Netherlands' first COVID-19 wave was significantly lower than … healthcare system, the standard treatment for HNC patients could be delivered within a shorter time interval [1].” We concur that there might be a change due to COVID-19. The change of incidence might be due to difficulty of healthcare facilities assessment during COVID-19 lockdown.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
